# Understanding the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

This bill is designed to help people with kidney disease get better care, access to treatment, and more choices about their healthcare. It tackles several problems that kidney disease patients face, from early detection to managing end-stage kidney failure.

The bill starts by making it easier to catch kidney disease early. Medicare will now cover kidney disease screening as part of annual wellness visits for seniors, which means more people will find out they have kidney problems before serious damage occurs. The bill also expands access to kidney disease education classes—these are now available to more patients and can be taught by a wider range of healthcare providers, including nurses and physician assistants, not just doctors. This matters because education helps patients understand their condition and make better decisions about their treatment options.

For people with advanced kidney failure who need dialysis, the bill addresses payment systems and innovation. It changes how Medicare pays for dialysis services to ensure payments accurately reflect the actual costs of care and support new, innovative treatments and technologies. The bill also requires Medicare to be more transparent about dialysis facility quality, making it easier for patients to compare facilities and choose where they receive treatment. Additionally, it creates bonus payments for dialysis facilities that provide excellent care, rewarding quality outcomes.

The bill also empowers patients by expanding their insurance options. People with kidney failure can now get Medigap supplemental insurance coverage (which helps pay for costs that Medicare doesn't cover), and there's a special enrollment period in 2023 for people who couldn't get this coverage before. The bill also allows people with kidney failure to keep their private insurance longer instead than being forced onto Medicare immediately, giving them more flexibility in choosing their coverage. Finally, the bill requires Medicare Advantage plans to maintain adequate networks of dialysis facilities so patients can access treatment without traveling excessive distances.

Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

Sewell, Terri A.

Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 This bill modifies provisions relating to Medicare coverage of treatments for chronic kidney disease. Specifically, the bill expands the Medicare annual wellness visit to include chronic kidney disease screening and allows certain Medicare beneficiaries who have End Stage Renal Disease (ESRD) to enroll in Medicare supplemental policies. It also (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services. The bill also extends the coordination period (from 30 months to 42 months) during which private health insurers may serve as the primary payers for Medicare beneficiaries with ESRD.